about
Case report of 5 siblings: malnutrition? Rickets? DiGeorge syndrome? Developmental delay?Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013Anticoagulants for cerebral venous thrombosis: harmful to patients?Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.Future body mass index modelling based on macronutrient profiles and physical activity.Cardiovascular Disease Death Before Age 65 in 168 Countries Correlated Statistically with Biometrics, Socioeconomic Status, Tobacco, Gender, Exercise, Macronutrients, and Vitamin K.BMI: a poor surrogate for diet and exercise in assessing risk of death.Reconsidering anticoagulant therapy in venous thromboembolism.Sustained-release morphine sulfate in the management of pain associated with acquired immune deficiency syndromeDoes anticoagulant treatment reduce the mortality of acute pulmonary embolism?Evidence basis for anticoagulants for cerebral sinus venous thrombosis? Reply by David K. CundiffEvidence-basis for anticoagulants for cerebral sinus venous thrombosis?Letter by Cundiff regarding editorial, "Cerebral venous thrombosis: another heparin controversy"Response to letter regarding article, "Anticoagulants for cerebral venous thrombosis: harmful to patients?"Response to letter regarding article, "anticoagulants for cerebral venous thrombosis: harmful to patients?"Guidelines for managing high blood pressure
P50
Q21245906-CE3ECD39-5BA4-4710-9629-FD86577E0188Q29616834-1C9D60C6-5DD7-437B-818B-70970CEDB969Q33411471-9D9BE4E3-BA48-4037-B72E-00BB27AF0D83Q36376945-829DD6C6-0AEF-4D79-A584-AAB2AB5B184EQ36552563-205DB910-FB24-407B-915F-C368032598EBQ37284364-4961DA96-3642-4900-9333-0F0ABC471271Q43832183-9B2F17EA-7627-41B9-BDBD-09B9745B9BF5Q43859768-21F134C0-69A0-4015-A0EA-6E34224489C9Q71522753-A93F0A28-6A3C-448D-BA61-9B3CCBD0E9FBQ74552501-612D609B-851B-48CE-AF03-329394F9733FQ86424637-1086A9AA-97FB-45A0-9BFB-74B29673734FQ86607915-5029F1DA-45B6-4B7D-88F6-D760036C5277Q87276098-35B7DCE3-76C1-4474-BC57-526B5E87276BQ87410590-DC6F4844-CAF2-41CD-B105-149F9552418BQ87704154-7BA7E2B1-030F-4BFC-8B0C-0E439C84FDAAQ95440034-996B7EFD-F740-4609-999C-A41275B4D438
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Cundiff
@ast
David Cundiff
@en
David Cundiff
@es
David Cundiff
@nl
type
label
David Cundiff
@ast
David Cundiff
@en
David Cundiff
@es
David Cundiff
@nl
prefLabel
David Cundiff
@ast
David Cundiff
@en
David Cundiff
@es
David Cundiff
@nl
P106
P1153
7003788101
P21
P31
P496
0000-0002-3206-9665